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Corneol Autofluorescence: An Indicator
of Diabetic Retinopathy
Thorsten R. Srolwijk, Jaap A. van Best, Jendo A. Oosterhuis, and Wouter Swart
The metabolic disorder in diabetics often results in progressive retinopathy with severe visual impair-
ment. Changes in metabolism can influence corneal autofluorescence. This has led to speculation that
diabetic retinopathy might be associated with changes in corneal autofluorescence. Corneal autofluo-
rescence of both eyes was determined by fluorophotometry in 94 insulin-dependent diabetes mellitus
patients and in 46 healthy controls to evaluate its correlation with diabetic retinopathy. The modified
Airlie House classification was used for grading diabetic retinopathy: (1) no or negligible retinopathy;
(2) minimal background retinopathy; (3) background retinopathy; and (4) (pre-) proliferative reti-
nopathy.
The corneal autofluorescence values of grade 1 retinopathy patients did not differ significantly from
those of the healthy controls (mean ± standard deviation in ng equivalent fluorescein/ml: 11.6 ± 3.0
and 11.4 ± 2.8, respectively; P = 0.8). The means of grade 2, 3, and 4 retinopathy patients (mean
± standard deviation in ngEq fluorescein/ml: 16.2 ± 4.4, 16.7 ± 4.3, 20.9 ± 5.4, respectively) were
significantly higher than the means of grade 1 patients and healthy controls (P < 0.004). The mean
values of patients with grade 4 were significantly higher than those of patients with grades 2 and 3 (P
< 0.01). The sensitivity and specificity of corneal autofluorescence as a screening test for diabetic
retinopathy were 80% and 76%, respectively; the positive predictive value for the presence of retinopa-
thy was 90%. The values for screening on (pre-) proliferative diabetic retinopathy were 68%, 72%, and
58%, respectively.
These data show corneal autofluorescence to be an adequate indicator of diabetic retinopathy. This
noninvasive technique, requiring less than one minute, can be applied efficiently as a clinical diagnostic
tool for retinopathy screening in diabetic patients. Invest Ophthalmol Vis Sci 32:92-97,1992.
The incidence of diabetes mellitus varies from 1.5%
to 5.0% per year, with a variation in prevalence of
7.8% to 45% in different racial and ethnic groups.1 In
diabetics, an average prevalence of 52% for diabetic
retinopathy has been reported.1 Diabetic retinopathy
has been the leading cause of blindness in Great Brit-
ain, North America, Europe, and Scandinavia since
1974.2 In the United States, current estimates of the
annual number of new cases of blindness due to dia-
betic retinopathy range from 12,000 to 24,000.3 Sev-
eral risk factors for development of retinopathy in dia-
betic patients have been established.4 So far, the dura-
tion of diabetes has been shown to be the most
powerful predictor of diabetic retinopathy.5
The measurement of corneal autofluorescence is a
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noninvasive technique that can be performed in less
than one minute. It recently has been shown to be a
useful parameter in ophthalmology because an in-
creased corneal autofluorescence was found in dia-
betic patients compared with healthy controls.6 The
presence and severity of diabetic retinopathy was not
considered in that study.
In the present study, the corneal autofluorescence
value was determined in insulin-dependent diabetes
mellitus (IDDM) patients with no or negligible reti-
nopathy and with three grades of retinopathy. The
intent was to assess its usefulness as an indicator for
the presence and severity of diabetic retinopathy and
to evaluate its efficacy as an ocular diagnostic tool for
the screening of retinopathy in a diabetic population.
Materials and Methods
Subject Selection
Ninety-four IDDM patients aged 16-70 years and
46 healthy controls participated in this study (Table
1). The IDDM patients were selected from the Leiden
University Hospital Outpatient Department of Oph-
thalmology, and the healthy controls were selected
92
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Table 1. Data of insulin-dependent diabetes mellitus






































* Patients without retinopathy (see text for retinopathy classification).
t Patients with minimal background retinopathy.
X Patients with background retinopathy.
§ Patients with (pre-)proliferative retinopathy.
through advertisements in local papers. Individuals
were selected on a normal aspect of all corneal layers
on slitlamp biomicroscopy without fluorescein stain-
ing, to avoid interference with the fluorophotometric
measurements. Excluded were individuals with con-
tact lenses and topical ocular medication as well as
IDDM patients with fundus photocoagulation per-
formed in the previous three months.
Diabetic retinopathy was graded using the modified
Airlie House classification,7 by two retinal specialists
using 30° fundus photographs covering seven stan-
dard fields and fluorescein angiography. Retinopathy
was classified into four grades based on the findings of
the most severely affected eye.
Grade 1. No or negligible retinopathy; at most two
microaneurysms per field. This grade is identified as
"without retinopathy" in the text.
Grade 2. Minimal background retinopathy; three
or more microaneurysms per field only.
Grade 3. Background retinopathy; microaneu-
rysms and one or more of the following items: retinal
hemorrhages, hard or soft exudates and/or intraret-
inal microvascular abnormalities (IRMA), venous
beading.
Grade 4. (Pre-) proliferative retinopathy; hemor-
rhages and microaneurysms and the following present
in more than 2 fields: soft exudates, IRMA, venous
beading, and/or new vessels and fibrous prolifera-
tions, and/or vitreous hemorrhages.
Age and diabetes duration in the four patient
groups are presented in Table 1.
The study was approved by the Medical Ethical
Committee of the Leiden University Hospital, and
informed consent was obtained from each individual
after the nature of the procedure had been explained
fully.
Instrumentation
Corneal autofluorescence measurements were per-
formed with a commercial fluorophotometer (Fluo-
rotron Master; Coherent Radiation, Palo Alto, CA)
fitted with the anterior segment adapter. The fluoro-
photometer had a 8.1 W tungsten halogen light
source. The peak transmission of the excitation filters
was 85%; for the fluorescence filters it was 90% (band
pass width at half height: 430-490 nm and 530-630
nm, respectively); The transmission outside each
bandwidth was effectively blocked (< 0.1%).8 Scan-
ning was restricted to about 1 mm before to 1 mm
past the cornea by modifying the commercial soft-
ware.6 Each scan consisted of 40 steps of 0.06 mm
each. At each step, the fluorescence was measured in a
volume of 0.5 mm X 1.9 mm X 0.1 mm for 0.2 sec-
onds. The total scan duration was 8 seconds.
Measurements
Corneal peak autofluorescence values were deter-
mined from four fluorophotometric scans of the cor-
nea of each eye. The average value of both eyes was
calculated because the values of right and left eyes
were found to be correlated.6 In the diabetic patients,
a 5 ml sample of venous blood was taken to assess the
momentaneous blood glucose level and percentage
glycosylated hemoglobin (HbAlc).
In addition, the corneal autofluorescence before
and after photocoagulation of the ocular fundus was
determined in five patients with retinopathy to evalu-
ate the effect of photocoagulation on corneal auto-
fluorescence.
Finally, the diurnal variation in the corneal auto-
fluorescence was determined in three patients by per-
forming seven consecutive corneal fluorophotometric
measurements at 9.00, 10.30, 11.00, 12.30, 13.30,
15.30, 16.00, and 17.00 hours, respectively.
Statistical Analysis
Retinopathy grading was performed without knowl-
edge of the corneal autofluorescence data and vice
versa. The normality of population distribution was
assessed using D'Agostino's test for departure from
normality.9 Commercial statistical software, includ-
ing multiple regression analysis, was used for evalua-
tion of the data (Statgraphics; STSC, Inc., Rockville,
MD). Differences in corneal autofluorescence values
between retinopathy grades were analyzed with Stu-
dent's t-test (two-tailed). Receiver operating charac-
teristic curve analysis was performed to determine the
decision level for optimal application of corneal auto-
fluorescence as a diagnostic test for detection of reti-
nopathy.10
Evaluation of Efficacy
The efficacy of corneal autofluorescence as a diag-
nostic tool for screening of retinopathy in diabetics
was evaluated by determining sensitivity, specificity,
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Fig. 1. Corneal autofluorescence expressed in ng equivalent fluo-
rescein/ml in IDDM patients without retinopathy (grade 1), pa-
tients with retinopathy (grades 2, 3, and 4) and healthy controls
(HC). The open squares and bars represent the mean value and the
standard error of the mean in each group. Retinopathy is graded
using the modified Airlie House classification (see text).
and predictive value of corneal autofluorescence for
detection of diabetic retinopathy (grades 2, 3 and 4)
and (pre-) proliferative retinopathy (grade 4), respec-
tively.
The sensitivity of a diagnostic ocular test is denned
as the percentage of positive diagnoses in all eyes that
have the disease. The specificity is defined as the per-
centage of diagnoses of absence of disease in all eyes
that do not have the disease.11
The positive predictive value of a diagnostic ocular
test is defined as the percentage of true diagnoses in all
eyes diagnosed as having the disease. The negative
predictive value is the percentage of true diagnoses in
all eyes diagnosed as not having the disease." Both
predictive values depend on the prevalence of the dis-
ease in a population.1'11
Results
The mean and standard deviation of the corneal
autofluorescence values in each retinopathy grade
and in the healthy controls was calculated because
these values were found to be distributed normally in
each group (P < 0.01).
The mean corneal autofluorescence values in dia-
betic retinopathy grades 1, 2, 3,4 and in healthy con-
trols are shown in Figure 1 (mean ± standard devia-
tion in ngEq fluorescein/ml: 11.6 ± 3.0, 16.2 ± 4.4,
16.7 ± 4.3, 20.9 ± 5.4 and 11.4 ± 2.8, respectively).
The mean values of patients with (minimal) back-
ground retinopathy (grades 2 and 3) and (pre-) prolif-
erative retinopathy (grade 4) were significantly higher
when compared to the mean value of patients without
retinopathy (average increases: 40% and 80%, respec-
tively; P = 0.004). The mean value of patients with
(pre-) proliferative retinopathy was 30% higher than
that of patients with (minimal) background retinopa-
thy (P < 0.01). The mean of patients without retinopa-
thy did not differ significantly from that of healthy
controls (P = 0.8).
The corneal autofluorescence values correlated sig-
nificantly with the severity of the retinopathy (linear
correlation coefficient r = 0.62, P < 0.0001). The mul-
tiple correlation coefficient obtained by a regression
procedure with severity of retinopathy and diabetes
duration as variables for the corneal autofluorescence
had a similar value (r = 0.65).
In the healthy controls, the corneal autofluores-
cence values were independent of age (r = 0.5, P
> 0.4). In the patients, the corneal autofluorescence
values correlated significantly with the diabetes dura-
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Fig. 2. Corneal autofluorescence versus dia-
betes duration in IDDM patients. Small open
squares: patients without retinopathy; crosses:
patients with (minimal) background retinopa-
thy (grade 2 and 3); closed squares: patients
with (pre-)proliferative retinopathy. The solid
line was obtained by a linear regression proce-
dure to the data points; the broken lines corre-
spond with the 2 times standard deviation.
Large square and bar corresponds with the
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* As in Table 1.
•f Number of photocoagulations in the ocular fundus.
% One hour before fundus photocoagulation.
§ Time after fundus photocoagulation.
blood glucose level (mean value: 11.5 mmol/L ± 6.1
SD, N = 84; r = 0.02, P > 0.8) or the HbAlc (mean
value: 8.0% ± 1.4 SD, N = 85; r = 0.1, P> 0.3).
There were no significant differences in mean dia-
betes duration between grades 2, 3 and 4 (Table 1; P
> 0.08). The mean diabetes duration in patients with-
out retinopathy was on average 62% shorter than in
those within the other retinopathy grades (Table 1; P
< 0.0001).
The corneal autofluorescence values of right and
left eyes were found to be correlated in the patient and
control groups (r > 0.9; P < 0.001).
The distribution of the 25 grade 1 patients (classi-
fied as "without retinopathy") was as follows: 16
showed no signs of retinopathy, 5 showed at most one
microaneurysm per field, and four showed at most
two microaneurysms per field.
Effect of Photocoagulation
The mean corneal autofluorescence values of 5 dia-
betic patients before and after laser treatment of the
ocular fundus and the number of photocoagulations
9.00 11.00 13.00 15.00 17.00
Time of Day (hr)
Fig. 3. Diurnal corneal autofluorescence in an IDDM patient.
Each open square and bar corresponds with the mean and standard
error of the mean of seven consecutive fluorophotometric measure-
ments. The broken line represents the mean value over the day.
are shown in Table 2. The difference in mean corneal
autofluorescence before and after treatment ranged
between -4.9% and +3.8% (mean difference: +2.9%).
Diurnal Variation
An example of the diurnal variation of corneal au-
tofluorescence in a diabetic patient is shown in Figure
3. The maximal deviations from the mean of the diur-
nal corneal autofluorescence values in the 3 patients
were 4.5%, 10%, and 4.1%, respectively (mean: 6.2%).
Efficacy for Retinopathy Screening
The decision level for a positive diagnosis for the
presence of diabetic retinopathy (grades 2, 3, and 4)
was calculated to be 14.2 ngEq fluorescein/ml; for
(pre-) proliferative retinopathy (grade 4) it was 17.0
ngEq fluorescein/ml.10 These values were found to
correspond to the mean corneal autofluorescence
value of healthy controls +1 SD and +2 SD, respec-
tively. The distributions of patients for evaluation for
retinopathy and (pre-) proliferative retinopathy
screening by corneal autofluorescence are presented
in Table 3 and 4, respectively.
The sensitivity and specificity of corneal autofluo-
rescence for detection of diabetic retinopathy in the
patients were 80% and 76%, respectively. The preva-
lence of diabetic retinopathy in our study was 73%

















•Grade 1, as in Table 1.
t Grades 2, 3 and 4, as in Table 1.
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Table 4. Distribution of diabetic patients without
or with (pre-) proliferative retinopathy
Number of patients
Without With
Corned autojluorescence (pre-) proliferative (pre-)proliferative







• Grade 1, 2, and 3, as in Table 1.
f Grade 4, as in Table 1.
values of 90% and 58%, respectively. Assuming a 52%
prevalence of diabetic retinopathy in the diabetic pop-
ulation,1 the positive and negative predictive values
were calculated to be 78% and 78%, respectively.
The sensitivity and specificity of corneal fluoropho-
tometry for the detection of (pre-) proliferative dia-
betic retinopathy were 68% and 72%, respectively.
The prevalence of (pre-) proliferative retinopathy in
our study was 36% (34/94), resulting in positive and
negative predictive values of 58% and 80%, respec-
tively. Assuming a 10% prevalence of (pre-) prolifera-
tive retinopathy in diabetic patients,1 the positive and
negative predictive values were calculated to be 21%
and 95%, respectively.
Discussion
Corneal autofluorescence was significantly in-
creased in diabetic patients with retinopathy when
compared to patients without retinopathy (average in-
creases: 40% in the (minimal) background retinopa-
thy group and 80% in the (pre-) proliferative retinopa-
thy group, respectively). Corneal autofluorescence in
patients with (pre-) proliferative retinopathy was sig-
nificantly higher than in those with (minimal) back-
ground retinopathy (average increase: 30%). Corneal
autofluorescence values showed a minimal diurnal
variation in diabetic patients (6%).
An accumulation of fluorophores in the diabetic
cornea related to duration of diabetes cannot ade-
quately explain the increased autofluorescence found
in patients with retinopathy because the corneal auto-
fluorescence is 30% higher in patients with (pre-) pro-
liferative retinopathy than in patients with (minimal)
background retinopathy, while diabetes duration did
not differ significantly between these groups (P
> 0.08). These findings are confirmed by the better
correlation of severity of retinopathy with corneal au-
tofluorescence than with diabetes duration (r = 0.62
and r = 0.50, respectively).
For the fluorophotometer used in this study, at least
88% of the corneal fluorescence signal in diabetic pa-
tients was proved to originate from corneal autofluo-
rescence, not from excitation light scattered at the
corneal surface and leaking through the fluorophoto-
meter filters.6 In that study, changes in the metabo-
lism of mitochondrial flavoproteins were held respon-
sible for the increased corneal autofluorescence in dia-
betics because: (1) the autofluorescence of these
proteins depends on metabolic changes in glucose lev-
els, oxygen availability, and the mitochondrial respira-
tory state;12'13 and (2) the fluorescence excitation and
emission wavelengths (X = 460 nm and X = 540 nm,
respectively) correspond with the excitation and
detection wavelengths of the fluorophotometer
used.14'15
The 30% increased corneal autofluorescence value
in (pre-) proliferative retinopathy patients when com-
pared to (minimal) background retinopathy patients
cannot be attributed to photocoagulation treatment,
because in 5 patients the values before and after pho-
tocoagulation were about the same (mean differ-
ence: 2.9%).
The unexpected correlation between the severity of
retinopathy and corneal autofluorescence suggests a
common pathogenesis, but explanations concerning
this correlation remain speculative. As a first explana-
tion, the vascular component of diabetes mellitus
causing specific microangiopathy and consequently
progressive retinopathy is probably interrelated with
the metabolic disorder (inappropriate elevation of
blood glucose level associated with alterations in lipid
and protein metabolism).16 This metabolic disorder
also affects the cornea, which might result in a progres-
sive metabolic impairment with a concomitant in-
crease of corneal autofluorescence. Hyperglycemia
did not seem to account for the increased corneal au-
tofluorescence found in our patients with retinopathy
because corneal autofluorescence was found to be in-
dependent of the blood glucose level and long-term
diabetic control (HbAlc). As a second explanation,
neovascular mediating substances are produced in the
retinas of patients with diabetic retinopathy.17 In
these patients, neovascularization of the iris (rubeosis
iridis) can occur, indicating the presence of these sub-
stances in the anterior chamber. These substances
have been shown to induce changes in corneal metab-
olism with corneal epithelial proliferation.17 This al-
tered corneal metabolism might result in an increase
of corneal autofluorescence.
This study shows corneal autofluorescence to be
more efficient than diabetes duration at predicting
onset and progression of retinopathy in diabetic pa-
tients. Until now, diabetes duration has been consid-
ered the most powerful predictor of diabetic retinopa-
thy.5 We found a sensitivity of 80% and a specificity of
76% for the detection of diabetic retinopathy through
Downloaded from iovs.arvojournals.org on 06/27/2019
No. 1 CORNEAL AUTOFLUORESCENCE AND DIABETIC RETINOPATHY / Srolwijk er al 97
corneal autofluorescence. The predictive value of cor-
neal autofluorescence for detection of retinopathy is
closely related to the frequency of retinopathy in the
diabetic population.10 In our study, 73% (69/94) of
the patients had diabetic retinopathy based on grad-
ing by the retinal specialists, which is a higher percent-
age than the average prevalence (52%) reported in the
diabetic population.1 This 52% prevalence would re-
sult in a positive predictive value of 78% and a nega-
tive predictive value of 78%. Therefore, corneal auto-
fluorescence can be a useful diagnostic tool for the
screening of retinopathy in a diabetic population.
Corneal fluorophotometry also was found to be
useful for screening of (pre-) proliferative retinopathy
in a diabetic population (sensitivity 68% and specific-
ity 72%, respectively). The percentage of missed (pre-)
proliferative retinopathy diagnoses using corneal au-
tofluorescence was 32% (11/34). This is an improve-
ment over direct ophthalmoscopy performed under
optimal conditions by internists (missed diagnoses,
52%), senior medical residents (missed diagnoses,
50%) and diabetologists (missed diagnoses, 33%)."
The positive predictive value and negative predictive
value were calculated to be 21% and 95%, respec-
tively, assuming a (pre-) proliferative retinopathy
prevalence of 10% in the diabetic population.1 The
low positive predictive value is a result of the low prev-
alence of (pre-) proliferative retinopathy in the dia-
betic population.
Measurement of corneal autofluorescence is per-
formed by a simple noninvasive technique. The mea-
surements cause no discomfort to the patient and can
be performed by nonspecialized personnel in a few
seconds. Fluorophotometric equipment for determi-
nation of corneal autofluorescence can be less sophis-
ticated and thus less expensive than the commercial
fluorophotometer used in this study because the in-
strument originally was developed for scanning of flu-
orescein in the vitreous.18 This technique could be
especially useful for general practitioners and diabe-
tologists because the results show that measurement
of corneal autofluorescence can be applied efficiently
as a screening test for diagnosing retinopathy in a dia-
betic population. This may help reduce the large num-
ber of diabetic patients routinely referred to ophthal-
mologists.
Key words: diabetic retinopathy, fluorophotometry, corneal
autofluorescence, diabetes mellitus, screening
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